Файл: part16.pdf

Page 1312​

DICOM PS3.16 2020a - Content Mapping Resource​

Code Value​

Code Meaning​

Definition​

Notes​

125273​

Left Ventricle Mass by Area​

Equation = Left Ventricle Mass by Area Length /​

Length - adjusted by Height​

Height^2.7​

Reference:​

Giovanni De Simone, et al. "Effect of Growth on​

Variability of Left Ventricular Mass: Assessment of​

Allometric Signals in Adults and Children and Their​

CapacitytoPredictCardiovascularRisk".NewYork,New​

York and Cincinnati, Ohio.​

125301​

Pre-coordinatedMeasurements​Measurements that are described by a single​

pre-coordinated code.​

125302​

Post-coordinatedMeasurements​Measurements that are described by a collection of​

(generally atomic) post-coordinated codes.​

125303​

Adhoc Measurements​

Measurements taken in an ad hoc fashion without any​

coordinated semantics.​

125304​

Untrackable Measurement​

The source system of the measurement does not​

maintain a persistent pre-coordinated code by which​

differentinstancesofthemeasurementcanbeassociated​

and tracked over multiple procedures.​

125305​

Finding Observation Type​

The type of observation made at the finding site, e.g.,​

whetheritisanobservationofthestructureofthefinding​

site, an observation of the behavior of the finding site, or​

an observation of the blood flow at the finding site.​

125306​

Measurement Type​

The type of derivation used to obtain the measurement​

value. E.g. whether it is taken directly, formed as a ratio,​

normalized against an index, or calculated using a more​

elaborate equation.​

125307​

Measured Property​

The property that is being measured.​

Examples include mass, diameter, peak blood velocity.​

125308​

Measurement Divisor​

The measurement which is the denominator of a​

measurement that is divided. This applies to​

measurements such as ratios or indexed values.​

125309​

Short Label​

A brief label, suitable for display on a screen or report.​

(Not suitable for matching).​

125310​

Staged Measurements​

Measurementsthatneedtobeassociatedwithaspecific​

stage in a procedure or acquisition protocol.​

125311​ Structure of the Finding Site​

The subject of a measurement is the physical structure​

of the Finding Site, such as the mass or diameter.​

125312​ Behavior of the Finding Site​

The subject of a measurement is the behavior of the​

Finding Site, such as the velocity or duration of motion.​

125313​

Indexed​

The measurement has been normalized by dividing it by​

an index value (such as Body Surface Area).​

125314​

Fractional Change​

The measurement is a change value expressed as a​

fractionofitsbaselinevalue.E.g.cardiacejectionfraction​

or fractional shortening.​

125315​

Calculated​

The measurement is calculated by incorporating one or​

more measured values into an equation other than a​

ratio, fractional change or indexed calculation.​

125316​

Directly measured​

Themeasurementisadirectoutputofthemeasurement​

tool.​

Page 1314​

DICOM PS3.16 2020a - Content Mapping Resource​

Code Value​

Code Meaning​

Definition​

Notes​

125907​

Targestar-B​

Targestar™-B ultrasonic contrast agent produced by​

Targeson LLC.​

125908​

Targestar-P​

Targestar™-P ultrasonic contrast agent produced by​

Targeson LLC.​

human or machine analysis of images for oncology​

evaluation.​

126002​

Dynamic Contrast MR​

A structured report containing the quantitative results of​

Measurement Report​

human or machine analysis of DCE-MR.​

126003​

PET Measurement Report​

A structured report containing the quantitative results of​

human or machine analysis of PET images.​

126010​

Imaging Measurements​

Measurements made on images​

126020​ Multiparametric MRI​

AnMRIprocedureinwhichmultipleparametersincluding​

diffusion, dynamic contrast and T2 are measured.​

parametersincludingdiffusion,dynamiccontrastandT2​

are measured.​

126022​

Multiparametric MRI of whole​ An MRI procedure of the whole body in which multiple​

body​

parametersincludingdiffusion,dynamiccontrastandT2​

are measured.​

126030​ Sum of segmented voxel​

The volume derived by summing the volumes of all the​

volumes​

voxels(andpartialvoxelsifthesegmentcontainspartially​

occupied voxels) included in the segment​

126031​ Peak Value Within ROI​

Maximum average gray value that is calculated from a​

1 cubic centimeter sphere placed within the region of​

interest.​

See Wahl RL, Jacene H, Kasamon Y, Lodge MA. From​

RECIST to PERCIST: Evolving Considerations for PET​

Response Criteria in Solid Tumors. Journal of Nuclear​

Medicine. 2009;50(Suppl 1):122S - 150S.​

126032​

Metabolic Volume​

The volume of a lesion (e.g., a tumor) ascertained​

throughinformationaboutitsmetabolicactivity(e.g.,SUV​

on PET).​

The volume may be defined on the same modality (e.g.,​

the MV on FDG-PET by some thresholding or other​

technique) or on another spatially registered modality​

(e.g., the lesion outline segmented on CT or MR).​

Doesnotapplytootherradiopharmaceuticalsthanthose​

involved in glucose metabolism.​

Abbreviated TLG. Synonymnous with "Tumor Lesion​

Glycolysis".​

126034​

Glycolysis​

The amount glycolytic activity summed across all voxels​

in a defined region or within a defined range of SUV (on​

FDG-PET).​

126035​

Total Lesion Proliferation​

The total activity of a lesion obtained as the product of​

its volume and its proliferative activity (on FLT-PET).​

The volume may be defined on the same modality (e.g.,​

the MV on FDG-PET by some thresholding or other​

technique) or on another spatially registered modality​

(e.g., the lesion outline segmented on CT or MR).​

Doesnotapplytootherradiopharmaceuticalsthanthose​

involved in cellular proliferation.​

Abbreviated TLP. Synonymnous with "Tumor Lesion​

Proliferation".​

126036​

Proliferative Activity​

The amount proliferative activity summed across all​

voxels in a defined region or within a defined range of​

SUV (on FLT-PET).​

Activity (SAM)​

version of TLG.​

SAMiscalculatedbydrawingavolumeofinterest(VOI1)​

aroundthetumourandalargerVOI(VOI2)aroundVOI1.​

Subtracting the background activity in VOI2-VOI1 from​

VOI1 yields SAM.​

SeeMertensetal."Standardizedaddedmetabolicactivity​

(SAM): a partial volume independent marker of total​

lesion glycolysis in liver metastases". Eur J Nucl Med​

Mol Imaging (2012) 39:1441-1448.​